Tropicamide
From Wikipedia, the free encyclopedia
 |
|
|
Tropicamide
|
|
| Systematic (IUPAC) name | |
| N-ethyl-3-hydroxy-2-phenyl-N- (pyridin-4-ylmethyl) propanamide | |
| Identifiers | |
| CAS number | 1508-75-4 |
| ATC code | S01FA06 |
| PubChem | 5593 |
| DrugBank | APRD00287 |
| Chemical data | |
| Formula | C17H20N2O2 |
| Mol. weight | 284.353 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 45% |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Tropicamide (troe-PIK-a-mide) is an acetylcholine receptor blocker, (a muscarinic antagonist). It is used to dilate (enlarge) the eye's pupil in order to allow better examination of the lens, vitreous humor, and retina. It is typically used during eye examinations, but may also be used before or after eye surgery.
Application of tropicamide can produce short acting mydriasis and cycloplegia.
Tropicamide is occasionally administered in eye drops in combination with hydroxyamphetamine (brand name Paremyd®) to dilate the pupil.
[edit] See also
 |
This medical article is a stub. You can help Wikipedia by expanding it. |
